SOURCE: InNexus Biotechnology Inc.

June 12, 2007 13:36 ET

InNexus CEO to Detail the Biotech Industry and InNexus' Position

DALLAS, TX--(Marketwire - June 12, 2007) - InNexus Biotechnology Inc., Scottsdale, Arizona (TSX-V: IXS) (OTCBB: IXSBF) -- Jeff Morhet, President and CEO, will be featured in an interview with Market News First Tuesday, June 12, 2007, at 1:00pm. CDT on www.mn1.com

InNexus Biotechnology Inc. has developed the ability to enhance the performance of antibody products and works with its partners to distribute more potent antibodies. During the discussion Morhet will explain InNexus' technologies as applied to antibodies as well as the medical market.

Join Morhet as he highlights the biotech industry, the company, and how InNexus has strategically positioned itself for success.

To learn more about InNexus, check out www.mn1.com Tuesday at 1 p.m. CDT.

About InNexus

InNexus Biotechnology Inc. is a drug development company commercializing the next generation of monoclonal antibodies based on its Dynamic Cross Linking (DXL™) technology improving the potency of existing antibody products while opening new markets and disease applications. DXL™ antibodies utilize unique, novel and patented methods and technologies of InNexus.

InNexus is headquartered in British Columbia with principal management based in Scottsdale, Arizona on the campus of Mayo Clinic and has its own in-house developmental facilities. These development facilities provide validation of protein and peptide discoveries, enabling InNexus (and its strategic partners) to advance novel drug therapeutics and diagnostics. To learn more about InNexus, please visit www.ixsbio.com.

The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of this news release. This news release may contain assumptions, estimates, and other forward-looking statements regarding future events. Such forward-looking statements involve inherent risks and uncertainties and are subject to factors, many of which are beyond the Company's control that may cause actual results or performance to differ materially from those currently anticipated in such statements.

About MN1.com

Market News First is an online market news provider that brings investors current news on the market. Market News First is the only online, live IPTV web site that brings real market news to investors and features live interaction with companies from the Bulletin Board to NYSE.

Through daily, live interviews, we bring you up to date on all the established companies and inform the investors of the newest opportunities within the market. Market News First offers one-on-one interviews with the presidents and CFOs of companies to deliver answers to the questions that investors may ask and provides them insight into the companies' present condition and future plans.

Contact Information